Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours. - Poret, Benjamin; Desrues, Laurence; Bonin, Marc-André; Pedard, Martin; Dubois, Martine; Leduc, Richard; Modzelewski, Romain; Decazes, Pierre; Morin, Fabrice; Vera, Pierre; Castel, Hélène; Bohn, Pierre; et al. (Biomolecules (2218-273X), 2020)